Helixmith Participates in 'International Pharmaceutical & Bio Industry Expo'... Introduces CGT Plant

[Asia Economy Reporter Lee Gwan-joo] Helixmith announced on the 13th that it will participate in the "International Pharmaceuticals & Bio Industry Expo," which will be held for four days starting from the 14th.

At this event, Helixmith plans to introduce the excellence and distinctiveness of its GMP (Good Manufacturing Practice) production facility for cell and gene therapy, the CGT Plant (Cell & Gene Therapy Plant), and seek partnerships.

The International Pharmaceuticals & Bio Industry Expo is a representative event in the pharmaceutical field hosted by Kyungyeon Exhibition and supported by the Ministry of Food and Drug Safety and the Korea Pharmaceutical and Bio-Pharma Manufacturers Association. Held at KINTEX in Ilsan, Helixmith will showcase its overall business including contract development and manufacturing organization (CDMO), raw material business, and health functional food business through its booth.

In particular, Helixmith plans to actively promote the CGT Plant, a specialized production facility for cell and gene therapy products established in September last year, targeting bio-pharmaceutical development companies aiming to develop cell and gene therapies. The CGT Plant has an operational and organizational system that meets the GMP standards for advanced biopharmaceuticals. It can provide solutions across all areas, including manufacturing itself, provision of proprietary vectors, process development, and analytical technology development.

Yoo Seung-shin, CEO of Helixmith, said, “Recently, the industry has been paying attention to the cell and gene therapy CDMO business,” and added, “We will introduce the technology and know-how accumulated over more than 20 years at this event, and we hope it will lead to meaningful and positive outcomes.”

This content was produced with the assistance of AI translation services.